Last updated 2026-06-18
- Raised $5.2M funding round led by Elron Ventures, Sep 2015
- Raised $1.1M funding round led by Seed Capital Dortmund, Feb 2014
Total raised
$6.3M
Last: 2015-09
Stage
Series A
Founded
2013
Headcount
21
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
Coramaze Technologies develops the Tripair, a simple, rapid, and effective percutaneous treatment for tricuspid valve disease. The treatment is intended to improve quality of life and reduce morbidity for heart failure patients suffering from tricuspid regurgitation. The Tripair implant is anchored a-traumatically in the right atrium, enabling full retrievability and intraprocedural efficacy evaluation while reducing regurgitation even in the most severe cases.
Funding history · 2 rounds · $6.3M total
Q&A
- What is Coramaze Technologies' primary focus?
- Coramaze Technologies develops the Tripair, a percutaneous treatment for tricuspid valve disease, aimed at improving the quality of life for heart failure patients.
- When was Coramaze Technologies founded?
- Coramaze Technologies was founded in January 2013.
- What is the current employee count for Coramaze Technologies?
- Coramaze Technologies has 11-50 employees.
- How much funding has Coramaze Technologies raised in total?
- Coramaze Technologies has raised a total of $6,264,000 USD.
- When was Coramaze Technologies' last funding round and who were the lead investors?
- Coramaze Technologies' last funding round was in September 2015, with Elron Ventures as a lead investor.
- Who are the key executives at Coramaze Technologies?
- Jochen Reinöhl serves as CEO, Grayston Licht as CTO, and Neil Moat as Chief Medical Officer at Coramaze Technologies.
- What is the current product stage of Coramaze Technologies' technology?
- Coramaze Technologies' product is currently in the clinical trial stage.
- What is the primary sector classification for Coramaze Technologies?
- Coramaze Technologies is primarily classified under Health Tech & Life Sciences.
- Does Coramaze Technologies hold any patents?
- Yes, Coramaze Technologies holds 1 patent.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
heart-failurevascularcardiologycathetersminimally-invasiveheart-diseasesmedical-technologiescardiovascularmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | tripairtechnology.com |
|---|
Identifiers & details
| Founded | 2013-1 |
|---|---|
| Employees (exact) | 21 |
Radar intelligence
Patents
| EPO | 17 |
|---|
Web history (Wayback)
| Domain | tripairtechnology.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|